These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33189452)

  • 1. Could a family history of type 2 diabetes be a risk factor to the endothelial damage in the patient with COVID-19?
    Alvarado-Vasquez N
    Med Hypotheses; 2021 Jan; 146():110378. PubMed ID: 33189452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood clots in COVID-19 patients: Simplifying the curious mystery.
    Biswas S; Thakur V; Kaur P; Khan A; Kulshrestha S; Kumar P
    Med Hypotheses; 2021 Jan; 146():110371. PubMed ID: 33223324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.
    Ricardo Criado P; Pincelli TPH; Criado RFJ; Abdalla BMZ; Belda Junior W
    Exp Dermatol; 2020 Oct; 29(10):936-944. PubMed ID: 32867008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 cell entry receptor ACE2 mediated endothelial dysfunction leads to vascular thrombosis in COVID-19 patients.
    Kumar A; Narayan RK; Kumari C; Faiq MA; Kulandhasamy M; Kant K; Pareek V
    Med Hypotheses; 2020 Dec; 145():110320. PubMed ID: 33032170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
    Bernard I; Limonta D; Mahal LK; Hobman TC
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019.
    Hayden MR
    J Int Med Res; 2020 Jul; 48(7):300060520939746. PubMed ID: 32722979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications.
    Ma Z; Yang KY; Huang Y; Lui KO
    J Mol Cell Cardiol; 2022 Mar; 164():69-82. PubMed ID: 34838588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implications of COVID-19 infection on the endothelium: A metabolic vascular perspective.
    Dalan R; Boehm BO
    Diabetes Metab Res Rev; 2021 Mar; 37(3):e3402. PubMed ID: 32871617
    [No Abstract]   [Full Text] [Related]  

  • 9. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2.
    Chen L; Li X; Chen M; Feng Y; Xiong C
    Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
    Colacci A; Bortone G; Maffei G; Marchesi S; Mescoli A; Parmagnani F; Pillo G; Ranzi A; Rotondo F; Serra S; Vaccari M; Zauli Sajani S; Mascolo MG; Jacobs MN
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):169-182. PubMed ID: 33412808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of angiotensin-converting enzyme 2 and proteases in COVID-19 patients: A potential role of cellular FURIN in the pathogenesis of SARS-CoV-2.
    Drak Alsibai K
    Med Hypotheses; 2020 Oct; 143():109893. PubMed ID: 32512290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Eur J Intern Med; 2020 Jun; 76():14-20. PubMed ID: 32336612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise as medicine for COVID-19: An ACE in the hole?
    Heffernan KS; Jae SY
    Med Hypotheses; 2020 Sep; 142():109835. PubMed ID: 32428811
    [No Abstract]   [Full Text] [Related]  

  • 14. Kawasaki-like disease in children with COVID-19: A hypothesis.
    Amirfakhryan H
    Med Hypotheses; 2020 Oct; 143():110117. PubMed ID: 32721809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minireview: The Introduction of COVID-19 and Microvascular Disease-Introduction of COVID-19 and the Relationship between Its Receptor and Diabetic Vascular Complications.
    Song Y; Ma Q; Lin P; Qin D; Lu D; Fan X
    Crit Rev Eukaryot Gene Expr; 2020; 30(6):499-508. PubMed ID: 33463917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
    Jagat J M; Kalyan K G; Subir R
    Diabetes Metab Syndr; 2020; 14(5):829-831. PubMed ID: 32540737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection.
    Mezoh G; Crowther NJ
    Adv Exp Med Biol; 2021; 1321():33-43. PubMed ID: 33656711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management.
    Vallianou NG; Evangelopoulos A; Kounatidis D; Stratigou T; Christodoulatos GS; Karampela I; Dalamaga M
    Curr Diabetes Rev; 2021; 17(6):e123120189797. PubMed ID: 33388022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review.
    Saba L; Gerosa C; Fanni D; Marongiu F; La Nasa G; Caocci G; Barcellona D; Balestrieri A; Coghe F; Orru G; Coni P; Piras M; Ledda F; Suri JS; Ronchi A; D'Andrea F; Cau R; Castagnola M; Faa G
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12609-12622. PubMed ID: 33336781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.